{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:19:07Z","timestamp":1740107947213,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"DOI":"10.1007\/s00784-023-05112-0","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T13:02:05Z","timestamp":1686747725000},"page":"4817-4826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between histopathological therapeutic effect and prognosis in oral cancer patients after preoperative S-1 chemotherapy followed by surgery"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4383-3865","authenticated-orcid":false,"given":"Mai","family":"Seki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7666-766X","authenticated-orcid":false,"given":"Takaaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsunari","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"5112_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00001813-199607000-00010","volume":"7","author":"T Shirasaka","year":"1996","unstructured":"Shirasaka T, Shimamoto Y, Ohshima H et al (1996) Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 7:548\u2013557","journal-title":"Anticancer Drugs"},{"key":"5112_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00001813-200402000-00001","volume":"15","author":"P Schoffski","year":"2004","unstructured":"Schoffski P (2004) The modulated oral fluropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors. Anticancer Drugs 15:85\u2013106","journal-title":"Anticancer Drugs"},{"key":"5112_CR3","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1002\/hed.26712","volume":"43","author":"M Seki-Soda","year":"2021","unstructured":"Seki-Soda M, Sano T, Ogawa M, Yokoo S, Oyama T (2021) CD15+ tumor infiltrating granulocytic cells can predict recurrence and their depletion is accompanied by good responses to S-1 with oral cancer. Head Neck 43:2457\u20132467","journal-title":"Head Neck"},{"key":"5112_CR4","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/sj.bjc.6602804","volume":"93","author":"M Tsukuda","year":"2005","unstructured":"Tsukuda M, Kida A, Fujii M et al (2005) Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br J Cancer 93:884\u2013889","journal-title":"Br J Cancer"},{"key":"5112_CR5","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1517\/14656566.2012.709234","volume":"13","author":"T Satoh","year":"2012","unstructured":"Satoh T, Sakata Y (2012) S-1 for the treatment of gastrointestinal cancer. Expert Opin Pharmacother 13:1943\u20131959","journal-title":"Expert Opin Pharmacother"},{"key":"5112_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/jrr\/rraa117","volume":"62","author":"N Imano","year":"2021","unstructured":"Imano N, Murakami Y, Kubo K, Kawahara D, Takeuchi Y, Nishibuchi I, Kimura T, Kochi M, Takakura Y, Shimizu W, Egi H, Uegami S, Ohge H, Takahashi S, Ohdan H, Nagata Y (2021) Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer. J Radiat Res 62:300\u2013308","journal-title":"J Radiat Res"},{"key":"5112_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.21873\/anticanres.14033","volume":"40","author":"M Sawasaki","year":"2020","unstructured":"Sawasaki M, Tsubamoto H, Nakamoto Y, Kakuno A, Sonoda T (2020) S-1, oxaliplatin, Nab-paclitaxel and itraconazole for conversion surgery for advanced or recurrent gastric cancer. Anticancer Res 40:991\u2013997","journal-title":"Anticancer Res"},{"key":"5112_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00280-019-03813-6","volume":"83","author":"T Kosaka","year":"2019","unstructured":"Kosaka T, Akiyama H, Miyamoto H, Sato S, Tanaka Y, Sato K, Kunisaki C, Endo I (2019) Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer. Cancer Chemother Pharmacol 83:1047\u20131055","journal-title":"Cancer Chemother Pharmacol"},{"key":"5112_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s10147-020-01657-2","volume":"25","author":"Y Nakamoto","year":"2020","unstructured":"Nakamoto Y, Noda M, Mikami R, Tokunaga Y, Okumoto T, Kawamura T, Fujiwara H, Doi S, Tomita N (2020) Phase II study of\u00a0S-1-based sequential combination chemotherapy including oxaliplatin plus bevacizumab and irinotecan with or without cetuximab for metastatic colorectal cancer: the SOBIC trial. Int J Clin Oncol 25:1285\u20131290","journal-title":"Int J Clin Oncol"},{"key":"5112_CR10","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.3748\/wjg.v17.i47.5221","volume":"17","author":"SG Gao","year":"2011","unstructured":"Gao SG, Jia RN, Feng XS, Xie XH, Shan TY, Pan LX, Song NS, Wang YF, Ding KL, Wang LD (2011) Therapeutic effects of combined oxaliplatin and S-1 in older patients with advanced gastric cardiac adenocarcinoma. World J Gastroenterol 17:5221\u20135226","journal-title":"World J Gastroenterol"},{"key":"5112_CR11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.ijrobp.2009.03.055","volume":"76","author":"T Nomura","year":"2010","unstructured":"Nomura T, Murakami R, Toya R et al (2010) Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma. Int J Radiat Oncol Biol Phys 76:1347\u20131352","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5112_CR12","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00280-013-2101-5","volume":"71","author":"H Harada","year":"2013","unstructured":"Harada H, Omura K, Tomioka H et al (2013) Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma. Cancer Chemother Pharmacol 71:1059\u20131064","journal-title":"Cancer Chemother Pharmacol"},{"key":"5112_CR13","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.ejca.2015.08.007","volume":"51","author":"GN Marta","year":"2015","unstructured":"Marta GN, Riera R, Bossi P, Zhong LP, Licitra L, Macedo CR, de Castro JG, Carvalho AL, William WN Jr, Kowalski LP (2015) Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: systematic review and meta-analysis. Eur J Cancer 51:2596\u20132603","journal-title":"Eur J Cancer"},{"key":"5112_CR14","first-page":"1027","volume":"46","author":"Y Matsumiya","year":"2019","unstructured":"Matsumiya Y, Imai T, Takeshita A, Meshii N, Katou I, Iwai S, Suematsu M, Omae M, Kanesaki T, Ota Y, Onishi T, Amino K, Sumi T, Niki A, Ueda M, Nakazawa M (2019) Clinicopathological evaluation of preoperative chemotherapy containing S-1 as a treatment for patients with oral squamous cell carcinoma during waiting time for surgery. Gan To Kagaku Ryoho 46:1027\u20131031","journal-title":"Gan To Kagaku Ryoho"},{"key":"5112_CR15","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.21873\/invivo.11366","volume":"32","author":"T Namikawa","year":"2018","unstructured":"Namikawa T, Ishida N, Tsuda S, Fujisawa K, Munekage E, Iwabu J, Munekage M, Uemura S, Tsujii S, Maeda H, Kitagawa H, Kobayashi M, Hanazaki KI (2018) Pathological complete response by S-1 chemotherapy in advanced gastric cancer. In Vivo 32:1211\u20131216","journal-title":"In Vivo"},{"key":"5112_CR16","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1200\/JCO.2012.43.3680","volume":"31","author":"H Ueno","year":"2013","unstructured":"Ueno H, Ioka T, Ikeda M, Ohkawa S, Yanagimoto H, Boku N, Fukutomi A, Sugimori K, Baba H, Yamao K, Shimamura T, Sho M, Kitano M, Cheng AL, Mizumoto K, Chen JS, Furuse J, Funakoshi A, Hatori T, Yamaguchi T, Egawa S, Sato A, Ohashi Y, Okusaka T, Tanaka M (2013) Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol 31:1640\u20131648","journal-title":"J Clin Oncol"},{"key":"5112_CR17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/jop.12923","volume":"48","author":"M Seki","year":"2019","unstructured":"Seki M, Sano T, Ogawa M, Yokoo S, Oyama T (2019) Histopathological changes in tumor budding between biopsy and resected specimens from patients treated with preoperative S-1 chemotherapy for oral cancer. J Oral Pathol Med 48:880\u2013887","journal-title":"J Oral Pathol Med"},{"key":"5112_CR18","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/cncr.23083","volume":"110","author":"AU Buzdar","year":"2007","unstructured":"Buzdar AU (2007) Preoperative chemotherapy treatment of breast cancer\u2013a review. Cancer 110:2394\u20132407","journal-title":"Cancer"},{"key":"5112_CR19","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s11605-020-04601-x","volume":"24","author":"EA Vega","year":"2020","unstructured":"Vega EA, Kutlu OC, Salehi O, James D, Alarcon SV, Herrick B, Krishnan S, Kozyreva O, Conrad C (2020) Preoperative chemotherapy for pancreatic cancer improves survival and R0 rate even in early stage I. J Gastrointest Surg 24:2409\u20132415","journal-title":"J Gastrointest Surg"},{"key":"5112_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s10151-020-02289-4","volume":"24","author":"J Arredondo","year":"2020","unstructured":"Arredondo J, Pastor E, Sim\u00f3 V, Beltr\u00e1n M, Casta\u00f1\u00f3n C, Magdaleno MC, Matanza I, Notarnicola M, Ielpo B (2020) Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review. Tech Coloproctol 24:1001\u20131015","journal-title":"Tech Coloproctol"},{"key":"5112_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0140-6736(14)61208-3","volume":"384","author":"GG Hanna","year":"2014","unstructured":"Hanna GG, Siva S, Plumridge N, Solomon B, Ball DL (2014) Preoperative chemotherapy for non-small-cell lung cancer. Lancet 384:232\u2013233","journal-title":"Lancet"},{"key":"5112_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. MAGIC trial participants. N Engl J Med 355:11\u201320","journal-title":"N Engl J Med"},{"key":"5112_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/jjco\/hys141","volume":"42","author":"T Izumo","year":"2012","unstructured":"Izumo T, Kirita T, Ariji E, Ozeki S, Okada N, Okabe S et al (2012) General rules for clinical and pathological studies on oral cancer: a synopsis. Jpn J Clin Oncol 42:1099\u20131109","journal-title":"Jpn J Clin Oncol"},{"key":"5112_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116965","volume":"10","author":"K Tsukahara","year":"2015","unstructured":"Tsukahara K, Kubota A, Hasegawa Y, Takemura H, Terada T, Taguchi T et al (2015) Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC). PLoS One 10:e0116965","journal-title":"PLoS One"},{"key":"5112_CR25","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/jjco\/hyx097","volume":"47","author":"H Hirakawa","year":"2017","unstructured":"Hirakawa H, Hanai N, Suzuki H, Nishikawa D, Matayoshi S, Hasegawa Y, Suzuki M (2017) Prognostic importance of pathological response to neoadjuvant chemotherapy followed by definitive surgery in advanced oral squamous cell carcinoma. Jpn J Clin Oncol 47:1038\u20131046","journal-title":"Jpn J Clin Oncol"},{"key":"5112_CR26","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1158\/0008-5472.CAN-14-0657","volume":"74","author":"J Kanterman","year":"2014","unstructured":"Kanterman J, Sade-Feldman M, Biton M, Ish-Shalom E, Lasry A, Goldshtein A, Hubert A, Baniyash M (2014) Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes. Cancer Res 74:6022\u20136035","journal-title":"Cancer Res"},{"key":"5112_CR27","doi-asserted-by":"publisher","first-page":"18278","DOI":"10.1038\/s41598-020-74067-z","volume":"10","author":"Y Matsuda","year":"2020","unstructured":"Matsuda Y, Ohkubo S, Nakano-Narusawa Y, Fukumura Y, Hirabayashi K, Yamaguchi H, Sahara Y, Kawanishi A, Takahashi S, Arai T, Kojima M, Mino-Kenudson M (2020) Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems. Sci Rep 10:18278","journal-title":"Sci Rep"},{"key":"5112_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5843\/jsot.20.255","volume":"20","author":"Y Tanaka","year":"2008","unstructured":"Tanaka Y (2008) The state and ploblems of judging histopathological effect. J Jpn Soc Oral Tumor 20:255\u2013261","journal-title":"J Jpn Soc Oral Tumor"},{"key":"5112_CR29","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/jso.24606","volume":"115","author":"N Choi","year":"2017","unstructured":"Choi N, Noh Y, Lee EK, Chung M, Baek CH, Baek KH, Jeong HS (2017) Discrepancy between cTNM and pTNM staging of oral cavity cancers and its prognostic significance. J Surg Oncol 115:1011\u20131018","journal-title":"J Surg Oncol"},{"key":"5112_CR30","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1111\/cas.14189","volume":"110","author":"R Almahmoudi","year":"2019","unstructured":"Almahmoudi R, Kasanen M, Sievil\u00e4inen M, Salem A, Pirinen M, Salo T, Al-Samadi A (2019) Prognostic value of blood and lymphatic vessel markers in tongue cancer: a systematic review. Cancer Sci 110:3424\u20133433","journal-title":"Cancer Sci"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-023-05112-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-023-05112-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-023-05112-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T06:24:23Z","timestamp":1691648663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-023-05112-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["5112"],"URL":"https:\/\/doi.org\/10.1007\/s00784-023-05112-0","relation":{},"ISSN":["1436-3771"],"issn-type":[{"type":"electronic","value":"1436-3771"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"16 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board for Clinical Research of Gunma University Hospital and conforms to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}